Study: Triple-drug protocol safe, effective for preventing clots

03/26/2012 | CardiologyToday.com

Adding cilostazol to a dual-antiplatelet treatment protocol of aspirin and clopidogrel is as safe and effective as a double-dose dual protocol for preventing blood clots in angioplasty patients, according to a study presented at a cardiology meeting. After a month, serious bleeding, cardiovascular-related death, myocardial infarction or stroke was seen in 1.2% of triple therapy patients, compared with 1.4% of patients receiving double-dose dual therapy. The trial will monitor patients for three more years.

View Full Article in:

CardiologyToday.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC